Drug Overdose Prevention Newscast

Having trouble viewing this email? View it as a Web page.

New DOP header

June 1, 2021

Here are your weekly updates from the Indiana Department of Health:

Extended-Release Buprenorphine Preferred by Patients: Study

Buprenorphine

A new study finds patients taking the opioid use disorder treatment buprenorphine prefer the extended-release (ER) version over the immediate-release version. The ER version is given as a weekly or monthly injection, while the immediate-release treatment is taken orally every day, according to a National Institutes of Health news release. The study found the ER injection of buprenorphine produced generally more positive patient-reported outcomes, including overall patient satisfaction, effectiveness and convenience. The researchers did not find any significant differences in illicit opioid use or side effects between the two treatment groups. 


Engagement in Drug Treatment Following Nonfatal Overdose Among People Who Inject Drugs in Appalachia

Many people who inject drugs (PWID) engage in drug treatment immediately after experiencing a non-fatal overdose. To better tailor interventions which are designed to facilitate drug treatment engagement in rural communities, the authors of a Johns Hopkins study identified supporting factors of starting any form of drug treatment after participants’ most recent overdose among PWID who reside in a rural county in West Virginia. The study found that one-third of participants started any form of drug treatment in the 30 days following their most recent overdoses. Factors associated with engaging in drug treatment included: recent buprenorphine or Suboxone injection, someone calling 911 after their most recent overdose, and older age. Results suggest that contact with emergency personnel after an overdose may represent an important opportunity to link PWID to drug treatment. The implementation of response teams trained in linking PWID to the services they require and helping persons navigate treatment systems may be a valuable intervention to reduce the harms of the opioid overdose crisis. 


Volunteers Needed: Hidden in Plain Sight (HIPS)

Volunteer

“Hidden in Plain Sight” (HIPS) is an interactive display designed to help parents of teens recognize unfamiliar hazards that are often in plain sight. By walking through a makeshift child's bedroom, parents learn to identify objects that could provide critical insights about risky behavior. Amid the clutter of clothing scattered on the floor, school supplies on a desk and personal care products on a vanity are some of the 100 items that can actually be signals that a young person could be involved in risky, harmful or even illegal activity. Intersect is looking for volunteers to help us educate the community about risky behaviors of our youth in the community.  

If interested please contact Wendy Cook at wcook@intersect.org.in or text the word: HIPS to 765-735-3382. 

Follow us! @INDTrauma

twitter

Check out our website:

world wide web logo
light blue divider

UPCOMING EVENTS

light blue divider

Webinar: Bipolar Disorder in the Black Community

Noon EDT, Thursday, June 3 

Bipolar disorder can be a severe mental illness that has forensic, community and psychosocial implications. It is also a major risk factor for suicide and drug abuse.  This webinar will explore the complexities of accurately identifying and diagnosing bipolar disorder, discuss pharmacological and non-pharmacological interventions, and examine the co-occurrence of bipolar and substance use disorders among African Americans.  

Click here to register.  

blue divider

CADCA Annual Survey of Coalitions: Live Q & A Session

Noon EDT, Thursday, June 3  

The Community Anti-Drug Coalitions of America (CADCA) Annual Survey of Coalitions (known as the “Annual Survey”) is a leading source of information on community-level substance misuse prevention. The survey provides insights into coalition processes, strategies and activities aimed to reduce substance misuse in efforts to improve population health. During this live session, Dr. Albert Terrillion, the director of evaluation and research for CADCA, will showcase the 2020 Annual Survey of Coalitions and detail what great information their state specific reports have to offer you! 

Click here to register.  

light blue divider

Naloxone Kit Making with Overdose Lifeline

5–7:30 pm EDT, Tuesday, June 1, June 9, & Saturday, June 29 

Overdose Lifeline is hosting multiple Naloxone kit making group nights. If you are free and willing to help, please join them one or all of the evenings. Meetings will be held in the dining room on the first floor at the Indiana Interchurch Center located at 1100 W42nd St. Indianapolis. No registration required.

light blue divider

ECHO Series: Behavioral Health for Individuals with Opioid Use Disorder

Noon – 1 p.m. EDT, Fridays June 6 through July 30

The IU School of Medicine will be hosting the Enhancing Community Health Outcomes (ECHO) series focused on the management of behavioral health conditions for individuals with Opioid Use Disorder (OUD). The Behavioral Health for OUD ECHO will be hosted virtually each week starting on June 6. This series is offered free of cost and the target audience includes clinicians, healthcare workers, recovery coaches, and other behavioral health professionals within Indiana.

Click here to register.

light blue divider

CIAO Time: A Quarterly Webinar Series: Chronic Pain

2-3:15 p.m. EDT, Tuesday, June 9  

The Center for Innovation in Academic Detailing on Opioids (CIAO) is continuing­­­­ its quarterly webinar series on topics related to opioid prescribing, opioid stewardship, and managing opioid use disorder. The topic of this webinar will be chronic pain management, including reviewing non-opioid approaches to chronic pain and the rationale for using opioids when appropriate for treating pain. 

Click here to register.